跳至主要内容
临床试验/NCT04640948
NCT04640948Unknown不适用

High Flow Nasal Cannula Therapy for Initial Oxygen Administration in Acute Hypercapnic Respiratory Failure - A Comparison Study of Two Current Standards of Care

Belfast Health and Social Care Trust2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2021年6月13日最近更新:
适应症

试验速览

阶段
不适用
入组人数
82
试验地点
2
主要终点
Proportion of patients requiring NIV in each cohort

研究概览

简要总结

Chronic lung conditions such as smoking related lung damage lead to breathing fail. This results in accumulation of gases such as carbon-di-oxide in the body especially during periods of illness known as exacerbation.

Current management of carbon-di-oxide accumulation is administration of oxygen, nebulisers, antibiotics etc and if necessary, provide a tight fitting mask around the face to provide breathing support. If this fails, then a patient is placed on a mechanical ventilator. The tight fitting mask therapy is also called non-invasive ventilation and is used widely but patients acceptability of the therapy is limited.

Providing a high flow of air with some oxygen could potentially provide the same benefit of the non-invasive ventilation and may also be better accepted by patients.

Currently the knowledge and evidence from studies suggest a beneficial role for this high flow therapy but this has not been investigated in well designed studies.

In the proposed study we aim to investigate whether use of the high flow therapy reduces the need for non-invasive ventilation in patients who present with a recent onset accumulation of carbon-di-oxide in their body due to long-term lung disease. If this shows benefit, it will lead to a bigger trial with patient benefiting by reduction in the non-invasive ventilation or indeed a need for an invasive breathing machine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Due to the nature of the intervention, the participants , care provider and investigator cannot be blinded but the outcome is objective and data will be analyzed by statistician independent of the study team.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients > 18 years of age
  • Acute Hypercapnic respiratory failure with pH < 7.35 and pCO2 > 6 KPa

排除标准

  • Age < 18 years
  • Pregnant or Breast-Feeding
  • Patient cannot read and understand English
  • Hypercapnia secondary to a drug toxicity or non-pulmonary aetiology
  • Hypercapnia secondary to exacerbation of asthma
  • Contraindication to NIV
  • Contraindication to HFNC
  • Not for escalation to NIV
  • GCS 8 or less
  • Shock defined as systolic < 90 mmHg or a reduction by 20mmHg from usual systolic BP despite volume resuscitation
  • Respiratory or cardio-respiratory arrest
  • Any other indication that requires immediate invasive/non-invasive mechanical ventilation

结局指标

主要结局

Proportion of patients requiring NIV in each cohort

时间窗: 6 hours

Proportion of patients who require NIV by 6 hours of intervention.

次要结局

  • Respiratory rate (Breath/minute)(At 1 hour, 6 hours and 24 hours.)
  • Hospital length of stay(From the date of randomization until hospital discharge or date of death from any cause, whichever came first, assessed up to 12 weeks.)
  • Heart rate (Beat/minute)(1 hour, 6 hours and 24 hours.)
  • Mean arterial pressure in millimeters of mercury(1 hour, 6 hours and 24 hours.)
  • In-hospital mortality(From the date of randomization until the date of death or hospital discharge, whichever came first, assessed up to 12 weeks.)
  • ICU length of stay(From the date of ICU admission until the date of last documented ICU discharge or date of death from any cause, whichever came first, assessed up to 12 weeks.)
  • PaO2 in Kilopascal(1 hour, 6 hours and 24 hours.)
  • pH(1 hour, 6 hours and 24 hours.)
  • Intubation rate(1 hour, 6 hours and 24 hours.)
  • ICU admission(From the date of randomization until the date of first documented admission to ICU, assessed up to 12 weeks.)
  • PaCO2 in Kilopascal(1 hour, 6 hours and 24 hours.)
  • Dyspnoea(1 hour, 6 hours and 24 hours.)
  • Patient comfort(1 hour.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

High VS Low Flow Nasal O2 for Acute Hypercapnic... | 临床试验